Facilitating European Clinical Research

ECRIN is a public, non-profit organisation that links scientific partners and networks across Europe
to facilitate multinational clinical research. We provide sponsors and investigators with advice,
management services and tools to overcome hurdles to multinational trials and enhance collaboration.

Our Work

We provide our 12 Member and Observer Countries with diverse trial support services
and contribute to infrastructure development projects with additional European and international partners.

ECRIN in Numbers

Member & Observer Countries

Million citizens represented

Trials in ECRIN portfolio

Average # of countries per trial

Events

Date:

The Research Data Alliance (RDA) 14th Plenary brings together data experts in research, industry and policy-making from around the world and all disciplines to discuss the theme 'Data Makes the Difference'.

The event, held in Helsinki, Finland from 23 to 25 October 2015, will address in particular the extensive potential of research data in:

  • Improving decision making
  • Tackling grand societal challenges
  • Engaging citizens in the creation of knowledge and betterment of society.

Data has enormous and diverse potential to change how we work, make decisions and empower citizens. The 14th RDA plenary will explore the extensive ways data can make the difference by bringing together diverse group of experts from all around the globe. During the plenary we will share and learn together and advance our abilities to use data in making a positive impact in the world to tackle its complex challenges.

The Plenary is co-hosted by Research Data Alliance Finland, CSC - IT Centre for Science, Aalto University, University of Helsinki, Federation of Finnish Learned Societies, and Finnish Meteorological Institute.

ECRIN will be attending the event. 

Learn more

Date:

A meeting entitled 'Facilitating high-quality multinational clinical research in Europe: ECRIN mission and vision' will be held at the Istituto Superiore di Sanità (ISS) on 23 October 2019. 

ISS coordinates the Italian Clinical Research Infrastructure Network (ItaCRIN), which aims to sustain independent clinical research and help investigators/sponsors promote (and join) multinational trials supported by ECRIN. Italy has been an ECRIN member since 2013. 

The purpose of the event is to improve knowledge of ECRIN and to encourage Italian participation in international trials, by promoting high-level, non-profit clinical research focused on the identification of innovati ve therapetuic strategies for the the benefit of public health. 

The conference is aimed at researchers and clinical investigators, medical doctors, grant office staff, clinical research organisations (CROs), and clinical trial unit (CTU) staff. 

Participation is free-of-charge, but registration is required. 

Documents and registration

Click here to download the meeting agenda

Click here to download the poster 

Click here to download the registration form (in Italian)

Learn more on the ISS website, or contact maria.buoncervello@iss.it

Date:

The Scientific and Technological Research Council of Turkey (TUBITAK) is organising a Rare Diseases Research Info Day and International Networking Event on 7 November 2019, in Istanbul, Turkey, at Sabancı University Nanotechnology Research and Application Center (SUNUM).

TUBITAK has committed ~1,5 M Euro for the European Joint Programme on Rare Diseases (EJP-RD) 2020 Call to support research partners from Turkey in the funded projects.

The 'Info Day and Brokerage Event' is intended to help interested parties connect with potential partners from Turkey (academia and industry) to prepare for the EJP-RD 2020 Call (which will open in December 2019).

Registration

Applications should be sent to event organisers by e-mail: dilem.hizlan@sabanciuniv.edu, jale.sahin@tubitak.gov.tr

Registration closes on 5 November 2019

Learn more

The EJP-RD initiative has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement N°825575.